NEW YORK—Ophthotech Corporation has elected Calvin W. Roberts, MD, senior vice president and chief medical officer, Eye Care at Bausch Health Companies and clinical professor of ophthalmology at Weill Medical College of Cornell University, to its board of directors, effective January 1. Dr. Roberts brings over 25 years of experience in the pharma/biotech industry. He is well-respected for his business expertise, industry experience and ophthalmic leadership, according to an announcement from Ophthotech. “We are excited to welcome Dr. Roberts, a well-known physician and experienced executive in our industry, to our board of directors,” said Glenn P. Sblendorio, chief executive officer and president of Ophthotech and David R. Guyer, MD, executive chairman of Ophthotech.

Sblendorio added, “The magnitude of relevant ophthalmic expertise and industry experience that Cal brings to Ophthotech is extremely valuable as we continue to develop and advance our pipeline of novel therapeutics and gene therapies for retinal diseases. We believe the addition of Cal to our board is another important step as we focus on creating value for shareholders.”

Dr. Roberts said, “As Ophthotech positions itself at the forefront of developing transformative treatments for orphan and age-related retinal diseases, I am excited to join the board of Ophthotech at this important time.” Dr. Roberts is a renowned specialist in cataract and refractive surgery and is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens.